Results
> Viela Bio - VIE
> 2021
Viela Bio ( $VIE )
Recent earnings result
- VIELA BIO EPS beats by $0.12, beats on revenue
Events & Annual meetings
There are no events at this time for this stock.
For list of VIE events, you may visit their Investor Relations website.
Viela is dedicated to the development and commercialization of novel, life-changing medicines for patients with a wide range of autoimmune and severe inflammatory diseases. We believe that our approach – which targets the underlying molecular pathogenesis of the disease – enables us to develop more precise therapies, identify patients more likely to respond to treatment and pursue multiple indications for each of our product candidates. Learn more about our clinical pipeline.
For list of VIE events, you may visit their Investor Relations website.
Recent results
-
$HNGR - Hanger, Inc.
Hanger EPS beats by $0.41, beats on revenue
-
$TTEC - TeleTech Holdings, Inc.
TTEC Holdings EPS beats by $0.51, beats on revenue
-
$LMND - Lemonade Inc.
Lemonade EPS beats by $0.04, beats on revenue
-
$AMBC - Ambac Financial Group, Inc.
Ambac Financial Group EPS beats by $0.80
-
$IPI - Intrepid Potash, Inc
Intrepid Potash EPS beats by $0.11, beats on revenue
-
$VIE - Viela Bio
VIELA BIO EPS beats by $0.12, beats on revenue
-
$OSUR - OraSure Technologies Inc
OraSure Technologies EPS misses by $0.04, beats on revenue
-
$MELI - MercadoLibre
MercadoLibre EPS of -$1.02, beats on revenue
-
$SWCH - Switch Inc
Switch EPS beats by $0.01, misses on revenue
-
$AMRC - Ameresco Inc
Ameresco EPS beats by $0.18, beats on revenue